Table 3.

Chronicity findings in LMN on rebiopsy

CaseGlomeruli/SclerosedIFTA, %Follow-Up, yrRebiopsy: Glomeruli/SclerosedRebiopsy: IFTA, %
117/1 (5.9%)0217/2 (11.8%)0
210/0 (0%)0226/0 (0%)0
33/0 (0%)01042/2 (4.8%)0
47/0 (0%)0742/19 (45.2%)25
  • Cases 1–3 are EXT1/EXT2-positive LMN and case 4 is EXT1/EXT2-negative LMN.